I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Armine K. Smith, M.D.
Director, Johns Hopkins Urologic Oncology at Sibley Memorial Hospital
Languages: English, Armenian, Russian
Expertise: Bladder Cancer, Kidney Cancer, Laparoscopic Kidney Surgery, Laparoscopic Nephrectomy, Minimally Invasive Surgery, Penile Cancer, Prostate Cancer, Robotic Prostatectomy, Robotic Surgery, Testicular Cancer, Ureteropelvic Junction Obstruction, Urethral Cancer, Urologic Surgery, Urological Oncology, Urology ...read more
Sibley Memorial Hospital
Appointment Phone: 410-955-6100
5255 Loughboro Road NW
Washington, DC 20016 map
Johns Hopkins Outpatient Center
Appointment Phone: 410-955-6100
601 N. Caroline St.
Urology, 4th Floor
Baltimore, MD 21287 map
Armine Smith, M.D., is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an assistant clinical professor of urology at Johns Hopkins University School of Medicine. Dr. Smith is board certified in urology by the American Board of Urology.
Dr. Smith has an expertise in advanced urologic surgery, including open and minimally invasive approaches to oncologic diseases and the latest robotic technologies. She specializes in many urologic malignancies, including bladder cancer, kidney cancer, penile cancer, prostate cancer and urethral cancer. In bladder cancer surgery, Dr. Smith specializes in complex urinary diversions, including continent orthotopic neobladder and continent catheterizable pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery.
Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer.
Dr. Smith previously served as a clinical instructor in surgery at Lerner College of Medicine and currently works as an assistant clinical professor of urology at George Washington University School of Medicine. She is also a clinical associate of the National Cancer Institute/Urologic Oncology Branch, and is working to earn her Master of Business Administration degree from Johns Hopkins University Carey Business School.
Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association.
Dr. Smith has earned the Cleveland Clinic Innovator Award and the Cleveland Clinic Housestaff Association Award, in addition to the John Quale Fellowship Travel Award and grants from the Greenberg Bladder Cancer Institute, the Cleveland Clinic Research Program Committee and the Flight Attendant Medical Research Institute. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has also lectured internationally and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidating risk factors for development of bladder cancer and overcoming resistance to conventional therapy regimens, including development of personalized targeted therapies.
- Director, Johns Hopkins Urologic Oncology at Sibley Memorial Hospital
Departments / Divisions
- Surgery at Sibley Memorial Hospital
Centers & Institutes
- MD, University of California San Francisco (2005)
- Cleveland Clinic / Urology (2011)
- National Institutes of Health-Credentialing Services Section / Urology (2014)
- American Board of Urology / Urology (2017)
Research & Publications
Selected PublicationsView all on Pubmed
Kerr BA, Miocinovic R, Smith AK, West XZ, Watts KE, Alzayed AW, Klink JC, Mir MC, Sturey T, Hansel DE, Heston WD, Stephenson AJ, Klein EA, Byzova TV. CD117+ cells in the circulation are predictive of advanced prostate cancer. Oncotarget. 2015 Jan 30;6(3):1889-97.
Smith AK, Matin SF, Jarrett TW. Wein: Campbell-Walsh Urology, 11th ed., Chapter 58/Urothelial Tumors of the Upper Urinary Tract and Ureter. Elsevier 2013
Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 2012 Oct 1;11(19):3649-55.
Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC, Jones SJ, Campbell SC, Hansel DE. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: Implications for conservative management. Urology. 2011 Jul;78(1):82-6.
Kerr BA, Miocinovic R, Smith AK, Klein EA, Byzova TV. Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model. Neoplasia. 2010 May;12(5):388-96
Jalalizadeh M, Smith AK, Miyamoto H. Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action. Clinical Immunology, Endocrine & Metabolic Drugs. 2016 Mar 31. ISSN: 2212-7089
Activities & Honors
- John Quale Fellowship Travel Award, 2012
- Loan Repayment Award, NIH Intramural, 2011 - 2014
- Cleveland Clinic Housestaff Association Award, 2010
- Cleveland Clinic Innovator Award, 2006
- UCSF Alumni Scholarship for Academic Excellence, 2005
- Chela Scholarship, University of California in San Francisco, 2003
- Cum Laude, University of Southern California, 2001
- Summa Cum Laude, Los Angeles Community College, 1999
- Edyth Dellacorte Scholarship for Excellence in Biology, 1999
- Full-time Dean's and President's Honors, Los Angeles Community College, 1998 - 1999
- Society of Urologic Oncology, 2011
- Society of Women in Urology, 2010
- American Urologic Association, 2006
- Society of Endourology, 2006 - 2011
- Golden Key National Honor Society, 2001
- Alpha Epsilon Delta Premedical Honor Society, 1999 - 2001
- Physiology Honors Club, 1995 - 1996
Videos & Media
Bladder Cancer | Q&A
Recent News Articles and Media Coverage
Some D.C. doctors are tackling cancer cures in a surprisingly low-tech way, Washington Business Journal, 2016.